We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Daily Aspirin Regimen Raises Hemorrhage Risk in Elderly

By HospiMedica International staff writers
Posted on 24 Sep 2018
Print article
The use of low-dose aspirin as a primary prevention strategy in older adults results in a significantly higher risk of major hemorrhage, according to a new study.

Researchers at Monash University (Melbourne, Australia), Hennepin Healthcare (Minneapolis, MN, USA), and other institutions conducted a study that enrolled 19,114 community-dwelling men and women in Australia and the United States who were 70 years of age or older, and did not have cardiovascular disease (CVD), dementia, or disability. Participants were randomly assigned to receive 100 mg of enteric-coated aspirin (9,525 people) or placebo (9,589). The primary end point was a composite of death, dementia, or persistent physical disability. Secondary end points included major hemorrhage and CVD.

The results revealed that after a median of 4.7 years of follow-up, the rate of CVD--defined as fatal coronary heart disease, nonfatal myocardial infarction (MI), fatal or nonfatal stroke, or hospitalization for heart failure--was 10.7 events per 1,000 person-years in the aspirin group, and 11.3 events per 1,000 person-years in the placebo group. The rate of major hemorrhage was 8.6 events per 1,000 person-years and 6.2 events per 1,000 person-years, respectively, or 38% higher. The study was published on September 16, 2018, in the New England Journal of Medicine (NEJM).

“The take-home message of such a complex, large, placebo-controlled study is that healthy older people contemplating how best to preserve their health will be unlikely to benefit from aspirin,” said lead author Professor John McNeil, PhD, director of the Monash University department of epidemiology and preventive medicine. “It means millions of healthy older people around the world who are taking low-dose aspirin without a medical reason may be doing so unnecessarily, because the study showed no overall benefit to offset the risk of bleeding.”

Low-dose aspirin is among the most widely used agents for the prevention of CVD. Its efficacy has been established in secondary prevention trials, in which the benefits associated with reducing the rates of both MI and ischemic stroke appear to outweigh the risk of hemorrhage. But the role of low-dose aspirin as a primary prevention strategy remains debated. In elderly populations, the risk of CVD is higher and the potential benefits of aspirin may accordingly be greater than in younger populations; however, an increased risk of bleeding has also been observed in the elderly age group.

Related Links:
Monash University
Hennepin Healthcare

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
Blood Pressure Cuff
Orbit-K
New
Surgical Light
TruLight 5000
New
Flexible Video Endocscopy System
EndoFLEX

Print article
Radcal

Channels

AI

view channel
Image: The WHO has conditionally recommended the use of algorithms in assisting with pediatric tuberculosis diagnosis (Photo courtesy of Pexels)

New Evidence-Based Algorithms Could Improve Diagnosis of Pediatric Tuberculosis

Tuberculosis (TB) continues to be one of the most prevalent causes of death among younger populations worldwide. Research indicates that over 96% of the deadly TB cases in children under the age of 15... Read more

Surgical Techniques

view channel
Image: Lighting up tumors could help surgeons remove them more precisely (Photo courtesy of Pexels)

‘Molecular Imaging’ Lights up Tumors for Surgeons to Enable Precise Removal

Neuroblastoma is a devastating form of childhood cancer that accounts for 8-10% of all childhood cancers and roughly 15% of all childhood deaths from cancer. Sadly, in almost one-third of cases, the cancer... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.